ALS surrogate markers. MRS. (Q30974180)

27 June 2017

1 reference

title

ALS surrogate markers. MRS. (English)

1 reference

amyotrophic lateral sclerosis

27 June 2017

main subject

1 reference

Kalra S

1

1 reference

27 June 2017

Arnold DL

series ordinal

2

1 reference

27 June 2017

publication date

1 September 2004

1 reference

Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases

27 June 2017

published in

1 reference

27 June 2017

volume

5 Suppl 1

1 reference

27 June 2017

page(s)

111-114

1 reference

Biological markers in the diagnosis and treatment of ALS.

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

Postmortem degradation of N-acetyl aspartate and N-acetyl aspartylglutamate: an HPLC analysis of different rat CNS regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

Motor neuron diseases: comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

1H spectroscopy in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

Reduction in metabolite transverse relaxation times in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

1H-MRS evidence of neurodegeneration and excess glutamate + glutamine in ALS medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

A prospective, randomized, placebo‐controlled evaluation of corticoneuronal response to intrathecal BDNF therapy in ALS using magnetic resonance spectroscopy: feasibility and results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

Decrease and recovery of N-acetylaspartate/creatine in rat brain remote from focal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

Effectiveness of revascularization surgery evaluated by proton magnetic resonance spectroscopy and single photon emission computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

Reversible decreases in N-acetylaspartate after acute brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17434470410019861

10.1080/17434470410019861

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference